First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension

First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension

Abstract VICTORY II study objective. Evaluation of Vamloset and Co-Vamloset safety and effectiveness in reaching target blood pressure (BP) level in patients with stages 23 arterial hypertension (AH). Materials and methods. Russian multicenter prospective clinical study conducted in 8 clinical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: I. E. Chazova, T. V. Martynyuk, V. O. Rodnenkov, B. Sh. Gorieva, A. N. Rogoza, M. V. Arkhipov, Yu. I. Grinshtein, O. D. Ostroumova, A. S. Galiavich, O. P. Rotar’, L. A. Haisheva, T. R. Kameneva
Formato: article
Lenguaje:RU
Publicado: IP Morozov P.V. 2020
Materias:
victory ii
russian clinical study
arterial hypertension
fixed combinations
valsartan
amlodipine
hydrochlorothiazide
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/d10d2629c2744a8cb865611fbf570069
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/d10d2629c2744a8cb865611fbf570069

Ejemplares similares